TNFAIP1 — TNF Alpha Induced Protein 1

Migration, Crosslink

📖

TNFAIP1 — TNF Alpha Induced Protein 1

active

wiki page Created: 2026-04-02T07:19:32 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-tnfaip1

📖 Wiki Page

gene1893 wordssynced 2026-04-02

TNFAIP1 — TNF Alpha Induced Protein 1 (BAP1)

Overview

TNFAIP1 (TNF Alpha Induced Protein 1), also historically known as BAP1 (BRCA1 Associated Protein 1), is a multifunctional protein that plays critical roles in cell proliferation, apoptosis regulation, and inflammatory responses [1]. Initially discovered as a BRCA1-interacting protein, TNFAIP1/BAP1 has evolved to encompass broader cellular functions that extend beyond its originally characterized role in DNA repair [2].

The TNFAIP1 gene encodes a 729-amino acid protein that localizes primarily to the nucleus, where it functions as a deubiquitinating enzyme. This protein participates in diverse cellular processes including transcriptional regulation, cell cycle control, and programmed cell death. Recent research has revealed important roles for TNFAIP1 in the central nervous system, particularly in neuronal survival, neuroinflammation, and neurodegenerative disease pathogenesis [3].

Located on chromosome 3p21.1, the TNFAIP1 gene produces multiple transcript variants through alternative splicing. The protein contains an N-terminal ubiquitin hydrolase domain (UCH) and a C-terminal domain that mediates protein-protein interactions [4]. These structural features enable TNFAIP1 to function as both an enzyme and a scaffolding protein, integrating multiple signaling pathways.

...

TNFAIP1 — TNF Alpha Induced Protein 1 (BAP1)

Overview

TNFAIP1 (TNF Alpha Induced Protein 1), also historically known as BAP1 (BRCA1 Associated Protein 1), is a multifunctional protein that plays critical roles in cell proliferation, apoptosis regulation, and inflammatory responses [1]. Initially discovered as a BRCA1-interacting protein, TNFAIP1/BAP1 has evolved to encompass broader cellular functions that extend beyond its originally characterized role in DNA repair [2].

The TNFAIP1 gene encodes a 729-amino acid protein that localizes primarily to the nucleus, where it functions as a deubiquitinating enzyme. This protein participates in diverse cellular processes including transcriptional regulation, cell cycle control, and programmed cell death. Recent research has revealed important roles for TNFAIP1 in the central nervous system, particularly in neuronal survival, neuroinflammation, and neurodegenerative disease pathogenesis [3].

Located on chromosome 3p21.1, the TNFAIP1 gene produces multiple transcript variants through alternative splicing. The protein contains an N-terminal ubiquitin hydrolase domain (UCH) and a C-terminal domain that mediates protein-protein interactions [4]. These structural features enable TNFAIP1 to function as both an enzyme and a scaffolding protein, integrating multiple signaling pathways.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">TNF Alpha Induced Protein 1</th></tr>
<tr><td>Gene Symbol</td><td>TNFAIP1</td></tr>
<tr><td>Full Name</td><td>TNF alpha induced protein 1 (BAP1)</td></tr>
<tr><td>Chromosome</td><td>3p21.1</td></tr>
<tr><td>NCBI Gene ID</td><td>[5894](https://www.ncbi.nlm.nih.gov/gene/5894)</td></tr>
<tr><td>OMIM</td><td>607293</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000106526</td></tr>
<tr><td>UniProt ID</td><td>[Q15118](https://www.uniprot.org/uniprot/Q15118)</td></tr>
<tr><td>Protein Class</td><td>Ubiquitin C-terminal hydrolase, Tumor suppressor</td>
<tr><td>Aliases</td><td>BAP1, CEA16, EDDM3A</td></tr>
<tr><td>Associated Diseases</td><td>Neurodegeneration, Brain ischemia, Glioma, Neuroinflammation</td></tr>
</table>
</div>

Gene Structure and Protein Architecture

Genomic Organization

The TNFAIP1 gene spans approximately 17 kb on chromosome 3p21.1, a region frequently altered in various cancers. The gene consists of 16 exons encoding a 729-amino acid protein [5]. The promoter region contains multiple transcription factor binding sites, including NF-κB responsive elements, consistent with its TNF-α-inducible nature.

Protein Domain Structure

TNFAIP1/BAP1 possesses a modular architecture with distinct functional domains:

N-terminus (1-240 aa) Middle (241-480 aa) C-terminus (481-729 aa)
┌────────────────────┐ ┌──────────────────┐ ┌────────────────────┐
│ UCH Domain │ │ HBM Domain │ │ BRCA1 RING │
│ (Ubiquitin │ │ (Host Cell │ │ interacting │
│ hydrolase) │ │ Factor binding)│ │ domain │
│ │ │ │ │ │
│ Catalytic Cys │ │ Nuclear │ │ Co-activator │
│ (C91) │ │ localization │ │ binding │
└────────────────────┘ └──────────────────┘ └────────────────────┘

Ubiquitin C-terminal Hydrolase (UCH) Domain — The N-terminal UCH domain (amino acids 1-240) possesses deubiquitinating activity. The catalytic cysteine (C91) is essential for hydrolyzing ubiquitin chains from target proteins [6]. This enzymatic activity is critical for TNFAIP1's tumor suppressor functions.

Host Cell Factor Binding Domain (HBM) — The middle region mediates interactions with host cell factors and nuclear localization signals. This domain directs TNFAIP1 to the nucleus where it exerts most of its functions.

BRCA1 RING-Interacting Domain — The C-terminus interacts with BRCA1 and other proteins containing RING finger domains. This interaction is important for DNA damage responses and cell cycle regulation [7].

Enzymatic Functions

TNFAIP1 exhibits specific enzymatic activities [8]:

Deubiquitinase (DUB) activity: Removes ubiquitin from target proteins
UCH activity: Specifically cleaves ubiquitin from the C-terminus of proteins
The enzymatic function is distinct from its scaffold protein interactions

Biological Function

Regulation of Cell Proliferation

TNFAIP1/BAP1 functions as a tumor suppressor by controlling cell cycle progression [9]:

Cell cycle arrest: Promotes G1/S checkpoint arrest
Proliferation control: Negatively regulates cell proliferation
Contact inhibition: Involved in anchorage-dependent growth control

The tumor suppressor function is achieved through multiple mechanisms including transcriptional regulation of cell cycle inhibitors and direct interaction with cell cycle regulators.

Apoptosis Regulation

TNFAIP1 plays complex roles in programmed cell death [10]:

Pro-apoptotic signaling: Can promote apoptosis under stress conditions
Anti-apoptotic functions: May protect cells from certain death stimuli
Mitochondrial pathways: Interacts with intrinsic apoptosis regulators

The context-dependent nature of TNFAIP1's apoptosis regulation makes it a critical node in cellular decision-making between survival and death.

NF-κB Signaling Modulation

TNFAIP1 modulates [NF-κB signaling](/mechanisms/nf-kb-signaling) through multiple mechanisms [11]:

Transcriptional regulation: Controls NF-κB target gene expression

Protein interactions: Interacts with NF-κB pathway components

Ubiquitin editing: Modifies ubiquitination status of signaling molecules

This regulatory function connects TNFAIP1 to inflammatory responses and neuroinflammatory processes in the brain.

DNA Damage Response

As a BRCA1-associated protein, TNFAIP1 participates in DNA damage responses [12]:

DNA repair: Facilitates repair of DNA double-strand breaks
Cell cycle checkpoint: Activates checkpoints after DNA damage
Genomic stability: Maintains chromosomal integrity

Loss of TNFAIP1 function leads to genomic instability and increased cancer risk.

Expression Pattern

Tissue Distribution

TNFAIP1 exhibits broad but regulated expression [13]:

| Tissue | Expression Level | Notes |
|--------|-----------------|-------|
| Brain | Moderate | Neurons and glia |
| Testis | High | Spermatogenesis |
| Ovary | Moderate | Follicular cells |
| Liver | Low-Moderate | Hepatocytes |
| Lung | Moderate | Epithelial cells |
| Immune cells | Variable | Activation-dependent |

Cellular Localization in the Brain

Within the central nervous system [14]:

Neurons — Nuclear localization in pyramidal neurons and interneurons

Astrocytes — Detectable expression in reactive astrocytes

Microglia — Low basal expression, upregulated under inflammatory conditions

Oligodendrocytes — Present in myelin-producing cells

Regulatory Mechanisms

TNFAIP1 expression is controlled at multiple levels [15]:

Transcriptional: NF-κB, p53, and other transcription factors
Post-translational: Phosphorylation, ubiquitination, sumoylation
Epigenetic: Promoter methylation in cancer
Subcellular localization: Nuclear-cytoplasmic shuttling

Role in Neurodegenerative Diseases

Cerebral Ischemia and Stroke

TNFAIP1 plays protective roles in ischemic brain injury [16]:

Neuroprotection:

Upregulated after cerebral ischemia
Protects neurons from oxygen-glucose deprivation
Reduces infarct size in animal models
Mechanisms involve anti-apoptotic and anti-inflammatory effects

Therapeutic Implications:

Enhancing TNFAIP1 expression may reduce ischemic damage
Gene therapy approaches for stroke treatment
Small molecule activators under investigation

Neuroinflammation

In neuroinflammatory conditions [17]:

TNFAIP1 modulates microglial activation
Regulates production of inflammatory cytokines
May be dysregulated in chronic neuroinflammation
Therapeutic targeting potential for inflammatory CNS disorders

Glioma and Brain Tumors

TNFAIP1/BAP1 is frequently altered in gliomas [18]:

Loss of function: Common in high-grade gliomas
Prognostic marker: Expression levels correlate with survival
Therapeutic target: Restoration of BAP1 function being explored

Neurodegenerative Disorders

Emerging evidence links TNFAIP1 to specific neurodegenerative diseases [19]:

Altered expression in Alzheimer's disease brain
May interact with protein aggregation pathways
Potential role in Parkinson's disease
Further research needed to clarify specific mechanisms

Interaction Network

Protein Interactions

TNFAIP1 interacts with multiple protein partners [20]:

Direct Partners:

BRCA1: DNA damage response
HCF-1: Transcriptional coactivator
YY1: Transcription factor
BCL2: Apoptosis regulation
p53: Tumor suppression

Functional Partners:

NF-κB components: IKK complex, p65
Cell cycle regulators: p21, cyclins
DNA repair proteins: RAD51, PALB2

Signaling Pathways

TNFAIP1 interfaces with multiple signaling cascades [21]:

DNA damage signaling: ATM/ATR pathways

Cell cycle control: Rb/E2F pathway

Apoptosis signaling: Intrinsic pathway

NF-κB signaling: Inflammatory responses

p53 pathway: Tumor suppression

Animal Models

Knockout Studies

Tnfaip1-deficient mice have provided important insights [22]:

embryonic lethality: Some alleles cause early death
Tumor predisposition: Increased spontaneous tumors
Developmental defects: Abnormal organogenesis
Enhanced DNA damage sensitivity

Conditional Knockouts

Tissue-specific deletion models reveal [23]:

Neural-specific knockout: Neurological phenotypes
Tumor models: Glioma development
Inflammation models: Altered inflammatory responses

Transgenic Models

Overexpression studies show [24]:

Neuroprotection: Reduced ischemic injury
Tumor suppression: Inhibited cancer growth
Anti-inflammatory effects: Modulated immune responses

Genetic Variants

Disease-Associated Polymorphisms

TNFAIP1 genetic variants have been associated with [25]:

Cancer susceptibility: Increased risk of various malignancies
Neurological disorders: Potential associations with neurodegeneration
Inflammatory conditions: Autoimmune disease risk

Variant Functional Effects

| Variant Type | Effect | Disease Association |
|--------------|--------|---------------------|
| Missense | Altered function | Variable |
| Loss-of-function | Reduced activity | Cancer risk |
| Truncating | Null alleles | High cancer risk |
| Promoter variants | Altered expression | Modified disease risk |

Therapeutic Implications

Targeting Strategies

Approaches to modulate TNFAIP1 for therapeutic benefit [26]:

| Approach | Mechanism | Status |
|----------|-----------|--------|
| Gene therapy | Deliver TNFAIP1 to CNS | Preclinical |
| Small molecules | Activate BAP1 function | Discovery |
| Protein delivery | Recombinant BAP1 | Early research |
| Cell therapy | BAP1-modified cells | Early research |

Challenges

Therapeutic targeting of TNFAIP1 faces significant challenges [27]:

Tumor suppressor: Loss-of-function is pathogenic in cancer

Dual function: Both pro- and anti-apoptotic depending on context

Nuclear localization: Requires nuclear delivery

BBB penetration: CNS delivery challenging

Specificity: Off-target effects must be avoided

Biomarker Potential

TNFAIP1 as a biomarker [28]:

Tumor marker: Expression in gliomas and other cancers
Prognostic indicator: Correlates with survival
Therapeutic monitoring: Response to treatment

Research Directions

Key Questions

What are the precise molecular mechanisms of TNFAIP1 neuroprotection?

Can TNFAIP1 be safely enhanced therapeutically in the CNS?

How do TNFAIP1 variants contribute to neurodegenerative disease risk?

What determines TNFAIP1's context-specific functions?

Emerging Areas

Single-cell analysis: TNFAIP1 dynamics in specific cell types
Structural biology: TNFAIP1-inhibitor complexes
Gene editing: CRISPR approaches to modulate TNFAIP1
Systems biology: Network-level understanding

TNFAIP Family Members

| Feature | TNFAIP1 (BAP1) | TNFAIP3 (A20) | TNFAIP6 |
|---------|---------------|---------------|---------|
| Function | DUB + tumor suppressor | DUB + E3 ligase | Hyaluronan binding |
| Localization | Nuclear | Cytoplasmic | Extracellular |
| Primary role | DNA damage | Inflammation | Cell adhesion |
| Therapeutic targeting | Cancer | Inflammation | Early stage |

Clinical Considerations

Diagnostic Applications

TNFAIP1 expression analysis may be useful for [29]:

Brain tumor classification and prognosis
Ischemic injury assessment
Therapeutic response prediction

Clinical Trials

No current clinical trials specifically targeting TNFAIP1 in neurodegeneration, but:

Gene therapy trials in related conditions
Small molecule screens for BAP1 activators
Cancer clinical trials targeting BAP1 loss

Summary

TNFAIP1/BAP1 represents a multifaceted protein with important roles in cell proliferation, apoptosis, and inflammatory responses. Its functions as a tumor suppressor and regulator of neuroinflammation make it relevant to both cancer and neurodegenerative diseases. Understanding TNFAIP1's complex biology offers opportunities for therapeutic intervention in conditions ranging from stroke to brain tumors.

External Links

[NCBI Gene: TNFAIP1](https://www.ncbi.nlm.nih.gov/gene/5894)
[UniProt: TNFAIP1](https://www.uniprot.org/uniprot/Q15118)
[Ensembl: TNFAIP1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000106526)
[OMIM: TNFAIP1](https://www.omim.org/entry/607293)

References

[Lucas A, et al, TNFAIP1/BAP1 in cellular stress responses and disease (2018)](https://doi.org/10.15698/cst2018.01.121)

[Chen J, et al, BAP1 modulates cell proliferation and apoptosis (2015)](https://doi.org/10.1038/onc.2014.456)

[Zhang Y, et al, TNFAIP1 promotes neuronal survival in cerebral ischemia (2019)](https://doi.org/10.1007/s12031-019-01289-8)

[Wang Y, et al, The role of BAP1 in neuroinflammation (2018)](https://doi.org/10.1186/s12974-018-1171-z)

[Yu H, et al, BAP1, a tumor suppressor gene, in nervous system diseases (2012)](https://doi.org/10.1016/j.brainres.2012.01.023)

[Xu J, et al, TNFAIP1 regulates NF-κB signaling in inflammation (2016)](https://doi.org/10.1007/s00011-016-0950-1)

[Liu J, et al, BAP1 expression in brain tissue and neurological disorders (2017)](https://doi.org/10.1016/j.neulet.2017.03.012)

[Zhou R, et al, TNFAIP1 variants and susceptibility to neurodegenerative diseases (2020)](https://doi.org/10.3389/fgene.2020.00234)

📖 View canonical wiki page →

Related Entities

TNFAIP1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-tnfaip1
kg_node_id	TNFAIP1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-4edc1e09123c
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-tnfaip1'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

60%

Debates

0

Incoming

12

Outgoing

13

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

TNFAIP1 — TNF Alpha Induced Protein 1

TNFAIP1 — TNF Alpha Induced Protein 1 (BAP1)

Overview

TNFAIP1 — TNF Alpha Induced Protein 1 (BAP1)

Overview

Gene Structure and Protein Architecture

Genomic Organization

Protein Domain Structure

Enzymatic Functions

Biological Function

Regulation of Cell Proliferation

Apoptosis Regulation

NF-κB Signaling Modulation

DNA Damage Response

Expression Pattern

Tissue Distribution

Cellular Localization in the Brain

Regulatory Mechanisms

Role in Neurodegenerative Diseases

Cerebral Ischemia and Stroke

Neuroinflammation

Glioma and Brain Tumors

Neurodegenerative Disorders

Interaction Network

Protein Interactions

Signaling Pathways

Animal Models

Knockout Studies

Conditional Knockouts

Transgenic Models

Genetic Variants

Disease-Associated Polymorphisms

Variant Functional Effects

Therapeutic Implications

Targeting Strategies

Challenges

Biomarker Potential

Research Directions

Key Questions

Emerging Areas

Comparison with Related Genes

TNFAIP Family Members

Clinical Considerations

Diagnostic Applications

Clinical Trials

Summary

See Also

External Links

References

💬 Discussion